Onto Innovation Inc.: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 10, 2023 and accepted by EDGAR at Aug 10, 2023, 21:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $190.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-01 | $389.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-02 to 2023-07-01 | $90.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-01-01 to 2023-07-01 | $184.4m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-04-02 to 2023-07-01 | $100.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-07-01 | $205.4m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-02 to 2023-07-01 | $27.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-07-01 | $54.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-02 to 2023-07-01 | $24.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-07-01 | $53.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-01 | $5.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | $25.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-01 | $55.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | $0.53 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-01 | $1.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | $0.53 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-01 | $1.12 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 49,274,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-01 | 49,175,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-01 | $81.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-07-01 | $12.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-01-01 to 2023-07-01 | $3.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-01 | $224.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $1.18bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $1.82bn | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $136.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $164.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-07-01 | $1.66bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-041470. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.